Total Payments
$359,898
2024 Payments
$689.28
Companies
66
Transactions
926
Medicare Patients
8,792
Medicare Billing
$397,619
Payment Breakdown by Category
Research$294,638 (81.9%)
Consulting$37,424 (10.4%)
Food & Beverage$16,124 (4.5%)
Other$8,622 (2.4%)
Travel$2,696 (0.7%)
Education$393.58 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $294,638 | 39 | 81.9% |
| Consulting Fee | $37,424 | 18 | 10.4% |
| Food and Beverage | $16,124 | 838 | 4.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,622 | 5 | 2.4% |
| Travel and Lodging | $2,696 | 11 | 0.7% |
| Education | $393.58 | 15 | 0.1% |
Payments by Type
Research
$294,638
39 transactions
General
$65,260
887 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $182,342 | 7 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $107,759 | 38 | $0 (2022) |
| Incyte Corporation | $19,561 | 46 | $0 (2024) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16,402 | 91 | $0 (2023) |
| Amgen Inc. | $6,952 | 53 | $0 (2020) |
| Genentech USA, Inc. | $6,174 | 100 | $0 (2020) |
| UCB, Inc. | $2,450 | 1 | $0 (2022) |
| Taiho Oncology, Inc. | $2,434 | 2 | $0 (2021) |
| Dova Pharmaceuticals | $2,404 | 5 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $1,538 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $689.28 | 6 | GENZYME CORPORATION ($143.18) |
| 2023 | $8,415 | 9 | Incyte Corporation ($5,516) |
| 2022 | $10,288 | 11 | Novartis Pharmaceuticals Corporation ($4,050) |
| 2021 | $6,266 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($3,025) |
| 2020 | $12,528 | 33 | Novartis Pharmaceuticals Corporation ($7,972) |
| 2019 | $78,178 | 290 | Takeda Pharmaceuticals U.S.A., Inc. ($51,816) |
| 2018 | $103,905 | 284 | Takeda Pharmaceuticals U.S.A., Inc. ($52,803) |
| 2017 | $139,629 | 287 | Celgene Corporation ($131,065) |
All Payment Transactions
926 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $129.24 | General |
| Category: Oncology | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 09/27/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 08/22/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $122.10 | General |
| Category: Oncology | ||||||
| 06/12/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $44.78 | General |
| Category: ONCOLOGY | ||||||
| 04/30/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $143.18 | General |
| Category: Oncology | ||||||
| 12/10/2023 | Novartis Pharmaceuticals Corporation | — | — | Cash or cash equivalent | $1,235.14 | Research |
| Study: Research Medical Writing and Publication Support | ||||||
| 10/11/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $101.25 | General |
| Category: ONCOLOGY | ||||||
| 09/29/2023 | Incyte Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,286.00 | General |
| 08/23/2023 | PFIZER INC. | BRAFTOVI (Drug) | Food and Beverage | In-kind items and services | $93.83 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $40.27 | General |
| Category: Oncology | ||||||
| 06/28/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Consulting Fee | Cash or cash equivalent | $1,181.25 | General |
| 05/17/2023 | ImmunoGen, Inc. | Elahere (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 05/04/2023 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $1,230.00 | General |
| 03/30/2023 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $121.82 | General |
| 10/12/2022 | Lilly USA, LLC | RETEVMO (Drug) | Food and Beverage | Cash or cash equivalent | $72.93 | General |
| Category: Oncology | ||||||
| 09/28/2022 | Incyte Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,875.00 | General |
| 09/27/2022 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $76.65 | General |
| Category: ONCOLOGY | ||||||
| 08/02/2022 | Incyte Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $743.00 | General |
| 06/01/2022 | Janssen Biotech, Inc. | ERLEADA (Drug), DARZALEX, BALVERSA | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Oncology | ||||||
| 04/13/2022 | G1 Therapeutics, Inc. | COSELA (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: ONCOLOGY | ||||||
| 03/17/2022 | Takeda Pharmaceuticals U.S.A., Inc. | EXKIVITY (Drug) | Food and Beverage | In-kind items and services | $115.79 | General |
| Category: ONCOLOGY | ||||||
| 02/11/2022 | UCB, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,450.00 | General |
| 02/07/2022 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $4,050.00 | General |
| 02/03/2022 | Incyte Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $743.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CC-5013-NHL-008 | Celgene Corporation | $128,517 | 1 |
| Pevonedistat-3001 PANTHER North and Latin American Investigator Meeting - All Day Beverages 4-20 | Takeda Pharmaceuticals U.S.A., Inc. | $87,696 | 25 |
| CC-5013-NHL-008 - A Phase 3B Randomized Study of Lenalidomide (CC-5013) Plus Rituximab Maintenance Therapy Followed by Lenalidomide Single-Agent Maintenance Versus Rituximab in Subjects with Relapsed/Refractory Follicu | Celgene Corporation | $37,925 | 1 |
| An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes HR MDS, Chronic Myelomonocytic Leukemia CMML and Low-Blast Acute Myelogenous Leukemia AML | Takeda Pharmaceuticals U.S.A., Inc. | $16,553 | 6 |
| A Phase 3B Randomized Study of Lenalidomide (CC-5013) Plus Rituximab Maintenance Therapy Followed by Lenalidomide Single-Agent Maintenance Versus Rituximab in Subjects with Relapsed/Refractory Follicular, Marginal Zone, or Mantle Cell Lymphoma(CA078-P10) (CC-5013-NHL-008) | Celgene Corporation | $13,319 | 1 |
| 4170 - CFZ Ph3 CRd (PX-171-009) ASPIRE | Amgen Inc. | $5,987 | 1 |
| AZA PH US 2004 CL003 | Celgene Corporation | $2,533 | 1 |
| Research Medical Writing and Publication Support | Novartis Pharmaceuticals Corporation | $1,235 | 1 |
| PUBLICATION SUPPORT PROVIDED IN CONNECTION WITH RESEARCH AGREEMENT | Novartis Pharmaceuticals Corporation | $614.00 | 1 |
| SINGLE-ARM, OPEN LABEL, PHASE II STUDY OF MBG453 (SABATOLIMAB) ADDED TO FDA APPROVED HYPOMETHYLATING AGENTS OF INVESTIGATOR'S CHOICE (IV/SC/ORAL) FOR PATIENTS WITH INTERMEDIATE, HIGH OR VERY HIGH RISK MYELODYSPLASTIC SYNDROME (MDS) AS PER IPSS-R CRITERIA (US MULTI-CENTER) (STIMULUS MDS-US) | Novartis Pharmaceuticals Corporation | $259.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 379 | 420 | $31,048 | $4,201 |
| 2022 | 19 | 1,506 | 2,296 | $178,170 | $35,664 |
| 2021 | 34 | 2,053 | 3,785 | $309,132 | $65,300 |
| 2020 | 52 | 4,854 | 33,162 | $1.7M | $292,453 |
Total Patients
8,792
Total Services
39,663
Medicare Billing
$397,619
Procedure Codes
107
All Medicare Procedures & Services
107 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 84165 | Protein measurement, serum | Office | 2023 | 205 | 226 | $16,498 | $2,226 | 13.5% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Office | 2023 | 174 | 194 | $14,550 | $1,976 | 13.6% |
| 84165 | Protein measurement, serum | Office | 2022 | 574 | 912 | $70,320 | $12,055 | 17.1% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Office | 2022 | 508 | 772 | $69,885 | $11,701 | 16.7% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2022 | 11 | 41 | $6,800 | $6,541 | 96.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 15 | $5,520 | $1,107 | 20.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 51 | 72 | $4,608 | $755.36 | 16.4% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2022 | 19 | 63 | $3,528 | $582.82 | 16.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 51 | 74 | $2,664 | $571.14 | 21.4% |
| 85055 | Reticulated (young) platelet measurement | Office | 2022 | 11 | 13 | $1,859 | $460.34 | 24.8% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2022 | 51 | 72 | $2,232 | $432.06 | 19.4% |
| 85379 | Coagulation function measurement, d-dimer; quantitative | Office | 2022 | 22 | 25 | $3,225 | $253.00 | 7.8% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 14 | 17 | $1,020 | $229.51 | 22.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 47 | 70 | $1,400 | $208.68 | 14.9% |
| 83550 | Iron binding capacity | Office | 2022 | 14 | 17 | $595.00 | $147.18 | 24.7% |
| 85046 | Red blood count automated, with additional calculations | Office | 2022 | 19 | 22 | $572.00 | $121.56 | 21.3% |
| 83540 | Iron level | Office | 2022 | 14 | 17 | $459.00 | $108.99 | 23.7% |
| 85730 | Coagulation assessment blood test, plasma or whole blood | Office | 2022 | 18 | 18 | $936.00 | $107.58 | 11.5% |
| 85610 | Blood test, clotting time | Office | 2022 | 20 | 23 | $690.00 | $98.05 | 14.2% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2022 | 32 | 36 | $1,296 | $96.60 | 7.5% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2022 | 15 | 17 | $561.00 | $87.71 | 15.6% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2021 | 17 | 112 | $17,920 | $18,006 | 100.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 107 | 144 | $52,992 | $11,981 | 22.6% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2021 | 12 | 282 | $50,760 | $5,004 | 9.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 192 | 344 | $22,016 | $3,604 | 16.4% |
About Dr. Roger Lyons, MD
Dr. Roger Lyons, MD is a Hematology healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508838285.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Lyons, MD has received a total of $359,898 in payments from pharmaceutical and medical device companies, with $689.28 received in 2024. These payments were reported across 926 transactions from 66 companies. The most common payment nature is "" ($294,638).
As a Medicare-enrolled provider, Lyons has provided services to 8,792 Medicare beneficiaries, totaling 39,663 services with total Medicare billing of $397,619. Data is available for 4 years (2020–2023), covering 107 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Location San Antonio, TX
- Active Since 02/06/2006
- Last Updated 02/26/2018
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1508838285
Products in Payments
- Revlimid (Drug) $179,776
- Kyprolis (Biological) $6,284
- PROMACTA (Drug) $5,599
- JAKAFI (Drug) $4,696
- VENCLEXTA (Biological) $4,432
- Vidaza (Drug) $2,533
- Doptelet (Drug) $2,404
- INQOVI (Drug) $2,310
- Mulpleta (Drug) $1,503
- CALQUENCE (Drug) $952.25
- Rituxan (Biological) $838.00
- XARELTO (Drug) $670.20
- KEYTRUDA (Biological) $620.46
- OPDIVO (Biological) $551.93
- Venclexta (Drug) $445.88
- IMBRUVICA (Drug) $378.22
- DARZALEX (Biological) $376.26
- TECENTRIQ (Biological) $362.29
- Cabometyx (Drug) $276.56
- ADCETRIS (Biological) $262.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in San Antonio
Dr. Robyn Scherber, Md, Mph, MD, MPH
Hematology — Payments: $57,580
Hematology $57,580
Dr. Joseph Holahan, M.d, M.D
Hematology — Payments: $8,588
Hematology $8,588
Joel Bessman, Md, MD
Hematology — Payments: $1,164
Hematology $1,164
Abhishek Pandya, Do, DO
Hematology — Payments: $1,010
Hematology $1,010
Jaime Estrada, Md, MD
Hematology — Payments: $936.48
Hematology $936.48
Dr. Alma Sanchez-Salazar, M.d, M.D
Hematology — Payments: $374.91
Hematology $374.91